nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ambulatory blood pressure measurement in the renal patient
|
Covic, Adrian |
|
2002 |
4 |
5 |
p. 369-376 |
artikel |
2 |
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: Evidence for and against the combination in the treatment of hypertension and proteinuria
|
Andersen, Niels Holmark |
|
2002 |
4 |
5 |
p. 394-402 |
artikel |
3 |
Angiotensin II and progressive renal insufficiency
|
Gaedeke, Jens |
|
2002 |
4 |
5 |
p. 403-407 |
artikel |
4 |
Evolving strategies for the use of combination therapy in hypertension
|
Gradman, Alan H. |
|
2002 |
4 |
5 |
p. 343-349 |
artikel |
5 |
Hypertensinogenic mechanism of the calcineurin inhibitors
|
Curtis, John J. |
|
2002 |
4 |
5 |
p. 377-380 |
artikel |
6 |
Hypertension as a cardiovascular risk factor in end-stage renal failure
|
Zoccali, Carmine |
|
2002 |
4 |
5 |
p. 381-386 |
artikel |
7 |
Literature alert
|
|
|
2002 |
4 |
5 |
p. 339-340 |
artikel |
8 |
Managing the hypertensive patient with ischemic heart disease
|
Rosendorff, Clive |
|
2002 |
4 |
5 |
p. 350-357 |
artikel |
9 |
Microalbuminuria in type 1 and type 2 diabetes mellitus: Evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy
|
Parving, Hans-Henrik |
|
2002 |
4 |
5 |
p. 387-393 |
artikel |
10 |
Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers
|
Weir, Matthew R. |
|
2002 |
4 |
5 |
p. 333-335 |
artikel |
11 |
Optimizing blood pressure control in the obese patient
|
Pischon, Tobias |
|
2002 |
4 |
5 |
p. 358-362 |
artikel |
12 |
Renal dysfunction as a cardiovascular risk factor
|
Ritz, Eberhard |
|
2002 |
4 |
5 |
p. 365-368 |
artikel |
13 |
Web alert
|
|
|
2002 |
4 |
5 |
p. 336-338 |
artikel |